Valuation: MedCap AB

Market Cap 8.03B 812M 721M 667M 609M 1.14B 77.08B 1.16B 3.15B 40.04B 3.05B 2.98B 129B P/E 2026 *
32.4x
P/E 2027 * 27.2x
Enterprise Value 8.12B 820M 729M 674M 616M 1.15B 77.9B 1.17B 3.19B 40.46B 3.08B 3.01B 130B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.93x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week+4.17%
Current month+2.39%
1 month+1.23%
3 months+4.38%
6 months+3.97%
Current year-2.28%
1 week 516.5
Extreme 516.5
543.5
1 month 499.2
Extreme 499.2
544.5
Current year 440
Extreme 440
582
1 year 440
Extreme 440
636
3 years 247
Extreme 247
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 2020-10-31
Director of Finance/CFO 52 2020-04-29
Corporate Officer/Principal 54 2019-12-31
Director TitleAgeSince
Chairman 52 2007-12-31
Director/Board Member 63 2022-04-30
Director/Board Member 66 2022-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Buy 1,500 0.0099%
2/9/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
2/6/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+1.23%+4.17%-3.33%+102.84% 811M
+1.21%+4.80%-2.31%+78.33% 175B
+0.53%-0.68%+30.88%+75.66% 147B
+0.85%+0.41%+35.21%+229.88% 96.43B
-2.37%-6.72%-31.80%+1.22% 85.28B
-0.96%-2.23%-16.84%+72.18% 81.7B
-1.62%-5.21%-26.69%+42.64% 77.39B
-1.84%-2.26%-15.65%+43.49% 72.31B
-1.12%-5.28%+48.80%+146.39% 45.21B
-0.35%+0.06%+6.50%+49.47% 44.24B
Average -0.44%-1.05%+2.48%+84.21% 82.6B
Weighted average by Cap. -0.28%-0.80%+3.32%+82.79%

Financials

2026 *2027 *
Net sales 2.4B 242M 215M 199M 182M 341M 23.01B 346M 941M 11.95B 909M 890M 38.39B 2.69B 271M 241M 223M 204M 382M 25.78B 388M 1.05B 13.39B 1.02B 997M 43.01B
Net income 256M 25.82M 22.94M 21.21M 19.37M 36.31M 2.45B 36.9M 100M 1.27B 96.88M 94.81M 4.09B 317M 32.03M 28.46M 26.32M 24.03M 45.05M 3.04B 45.79M 124M 1.58B 120M 118M 5.07B
Net Debt 85M 8.59M 7.63M 7.06M 6.44M 12.08M 815M 12.28M 33.34M 424M 32.23M 31.54M 1.36B -148M -15M -13.33M -12.33M -11.26M -21.1M -1.42B -21.45M -58.25M -740M -56.31M -55.1M -2.38B
Projected Income Statement - Annual - MedCap AB
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
647
Date Price Change Volume
26-10-16 SEK 536.50 +1.23% 11,986
26-10-15 SEK 530.00 -1.30% 14,355
26-10-14 SEK 537.00 +1.80% 12,932
26-10-13 SEK 527.50 0.00% 10,251
26-10-12 SEK 527.50 +2.43% 20,275
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
536.50SEK
Average target price
640.00SEK
Spread / Average Target
+19.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MedCap AB
  1. Stock Market
  2. Stocks
  3. MCAP Stock